Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (36)
Habiba Alaa, Mariam Abdelaziz, Maryam Mustafa, Mustafa Mansour, Salma Magdy, Salma Mohsen, Yomna El-Karamany & Alyaa Farid. (2023) Therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats. Scientific Reports 13:1.
Crossref
Crossref
Eunsoo Moon, Kyungwon Kim, Timo Partonen & Outi Linnaranta. (2022) Role of Melatonin in the Management of Sleep and Circadian Disorders in the Context of Psychiatric Illness. Current Psychiatry Reports 24:11, pages 623-634.
Crossref
Crossref
Jonathan P. Hintze & Jack D. Edinger. (2022) Hypnotic Discontinuation in Chronic Insomnia. Sleep Medicine Clinics 17:3, pages 523-530.
Crossref
Crossref
Arani Das, Manoj Prithviraj & Palani Selvam Mohanraj. (2022) Role of Melatonin in the Management of Substance Addiction: A Systematic Review. Cureus.
Crossref
Crossref
Alexandre González-Rodríguez, José Haba-Rubio, Judith Usall, Mentxu Natividad, Virginia Soria, Javier Labad & José A. Monreal. (2022) Hormone Targets for the Treatment of Sleep Disorders in Postmenopausal Women with Schizophrenia: A Narrative Review. Clocks & Sleep 4:1, pages 52-65.
Crossref
Crossref
Victor M. Tang & Simon J. C. Davies. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
2217
2242
.
Mélinée Chapoutot, Laure Peter-Derex, Hélène Bastuji, Wendy Leslie, Benjamin Schoendorff, Raphael Heinzer, Francesca Siclari, Alain Nicolas, Patrick Lemoine, Susan Higgins, Alexia Bourgeois, Guillaume T. Vallet, Royce Anders, Marc Ounnoughene, Jessica Spencer, Francesca Meloni & Benjamin Putois. (2021) Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders. International Journal of Environmental Research and Public Health 18:19, pages 10222.
Crossref
Crossref
Cathy Duan, Zoe M Jenkins & David Castle. (2021) Therapeutic use of melatonin in schizophrenia: A systematic review. World Journal of Psychiatry 11:8, pages 463-476.
Crossref
Crossref
Laura Palagini, Raffaele Manni, Eugenio Aguglia, Mario Amore, Roberto Brugnoli, Stéphanie Bioulac, Patrice Bourgin, Jean-Arthur Micoulaud Franchi, Paolo Girardi, Luigi Grassi, Régis Lopez, Claudio Mencacci, Giuseppe Plazzi, Julia Maruani, Antonino Minervino, Pierre Philip, Sylvie Royant Parola, Isabelle Poirot, Lino Nobili, Giovanni Biggio, Carmen M. Schroder & Pierre A. Geoffroy. (2021) International Expert Opinions and Recommendations on the Use of Melatonin in the Treatment of Insomnia and Circadian Sleep Disturbances in Adult Neuropsychiatric Disorders. Frontiers in Psychiatry 12.
Crossref
Crossref
Julie Anja Engelhard Christensen, Poul Jørgen Jennum, Birgitte Fagerlund & Lone Baandrup. (2021) Association of neurocognitive functioning with sleep stage dissociation and REM sleep instability in medicated patients with schizophrenia. Journal of Psychiatric Research 136, pages 198-203.
Crossref
Crossref
Victor M. Tang & Simon J. C. Davies. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
26
.
Michel Bourin. 2021. Psychiatry and Neuroscience Update. Psychiatry and Neuroscience Update
261
277
.
P.A. Geoffroy, J.-A. Micoulaud Franchi, R. Lopez & C.M. Schroder. (2020) Republication de : Utilisation de la mélatonine dans les troubles psychiatriques chez l’adulte : recommandations d’experts de la Société française de recherche et médecine du sommeil (SFRMS). Médecine du Sommeil 17:3, pages 195-209.
Crossref
Crossref
Armando L. Morera-Fumero, Lourdes Fernandez-Lopez & Pedro Abreu-Gonzalez. (2020) Melatonin and melatonin agonists as treatments for benzodiazepines and hypnotics withdrawal in patients with primary insomnia. A systematic review. Drug and Alcohol Dependence 212, pages 107994.
Crossref
Crossref
Jonathan P. Hintze & Jack D. Edinger. (2020) Hypnotic Discontinuation in Chronic Insomnia. Sleep Medicine Clinics 15:2, pages 147-154.
Crossref
Crossref
Lone Baandrup. (2020) Polypharmacy in schizophrenia. Basic & Clinical Pharmacology & Toxicology 126:3, pages 183-192.
Crossref
Crossref
Frank M. C. Besag, Michael J. Vasey, Kim S. J. Lao & Ian C. K. Wong. (2019) Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review. CNS Drugs 33:12, pages 1167-1186.
Crossref
Crossref
P.A. Geoffroy, J.-A. Micoulaud Franchi, R. Lopez & C.M. Schroder. (2019) The use of melatonin in adult psychiatric disorders: Expert recommendations by the French institute of medical research on sleep (SFRMS). L'Encéphale 45:5, pages 413-423.
Crossref
Crossref
Syed Suhail Andrabi, Shruti Vishnoi, Medha Kaushik, Khina Parveen, Heena Tabassum, Mohd. Akram & Suhel Parvez. (2019) Reversal of Schizophrenia-like Symptoms and Cholinergic Alterations by Melatonin. Archives of Medical Research 50:5, pages 295-303.
Crossref
Crossref
Marco Aurélio Vinhosa Bastos Jr.Paulo Roberto Haidamus de Oliveira Bastos, Renata Boschi Portella, Leonardo Fabrício Gomes Soares, Ricardo Brilhante Conde, Paulo Milton Fernandes RodriguesJr.Jr. & Giancarlo Lucchetti. (2019) Pineal gland and schizophrenia: A systematic review and meta-analysis. Psychoneuroendocrinology 104, pages 100-114.
Crossref
Crossref
D. A. Sychev, A. V. Zhuchkov, O. V. Tereshchenko & D. V. Ivashchenko. (2019) Tapering (deprescribing) of benzodiazepine tranquilizers. Neurology, Neuropsychiatry, Psychosomatics 11:1, pages 89-95.
Crossref
Crossref
Lone Baandrup, Julie A. E. Christensen, Birgitte Fagerlund & Poul Jennum. (2019) Investigation of sleep spindle activity and morphology as predictors of neurocognitive functioning in medicated patients with schizophrenia. Journal of Sleep Research 28:1.
Crossref
Crossref
Hope M. Foley & Amie E. Steel. (2019) Adverse events associated with oral administration of melatonin: A critical systematic review of clinical evidence. Complementary Therapies in Medicine 42, pages 65-81.
Crossref
Crossref
Daniel E. Vigo & Daniel P. Cardinali. 2019. Psychiatry and Neuroscience Update. Psychiatry and Neuroscience Update
427
451
.
Justine W. Welsh, Valeria Tretyak, R. Kathryn McHugh, Roger D. Weiss & Olivera Bogunovic. (2018) Review: Adjunctive pharmacologic approaches for benzodiazepine tapers. Drug and Alcohol Dependence 189, pages 96-107.
Crossref
Crossref
Jonathan P. Hintze & Jack D. Edinger. (2018) Hypnotic Discontinuation in Chronic Insomnia. Sleep Medicine Clinics 13:2, pages 263-270.
Crossref
Crossref
Masakazu Hatano, Hiroyuki Kamei, Risa Inagaki, Haruna Matsuzaki, Manako Hanya, Shigeki Yamada & Nakao Iwata. (2018) Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study. Clinical Psychopharmacology and Neuroscience 16:2, pages 184-189.
Crossref
Crossref
Lone Baandrup, Bjørn H Ebdrup, Jesper Ø Rasmussen, Jane Lindschou, Christian Gluud & Birte Y Glenthøj. (2018) Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users. Cochrane Database of Systematic Reviews 2018:3.
Crossref
Crossref
Sue Wilson & Hugh Selsick. 2018. Sleep Disorders in Psychiatric Patients. Sleep Disorders in Psychiatric Patients
121
148
.
Lone Baandrup, Birgitte Fagerlund & Birte Glenthoj. (2016) Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo. European Archives of Psychiatry and Clinical Neuroscience 267:2, pages 163-171.
Crossref
Crossref
Tasuku Hashimoto, Akihiro Shiina, Tadashi Hasegawa, Hiroshi Kimura, Yasunori Oda, Tomihisa Niitsu, Masatomo Ishikawa, Masumi Tachibana, Katsumasa Muneoka, Satoshi Matsuki, Michiko Nakazato & Masaomi Iyo. (2016) Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial. Annals of General Psychiatry 15:1.
Crossref
Crossref
Lone Baandrup, Ole Bernt Fasmer, Birte Yding Glenthøj & Poul Jørgen Jennum. (2016) Circadian rest-activity rhythms during benzodiazepine tapering covered by melatonin versus placebo add-on: data derived from a randomized clinical trial. BMC Psychiatry 16:1.
Crossref
Crossref
Daniel P. Cardinali, Diego A. Golombek, Ruth E. Rosenstein, Luis I. Brusco & Daniel E. Vigo. (2016) Assessing the efficacy of melatonin to curtail benzodiazepine/Z drug abuse. Pharmacological Research 109, pages 12-23.
Crossref
Crossref
Lone Baandrup, Birte Yding Glenthøj & Poul Jørgen Jennum. (2016) Objective and subjective sleep quality: Melatonin versus placebo add-on treatment in patients with schizophrenia or bipolar disorder withdrawing from long-term benzodiazepine use. Psychiatry Research 240, pages 163-169.
Crossref
Crossref
Daniel Pedro CardinaliDaniel Pedro Cardinali. 2016. Ma Vie en Noir. Ma Vie en Noir
131
154
.
Angela Wright, Jacqueline Diebold, Jaskiran Otal, Carly Stoneman, Jonathan Wong, Christine Wallace & Mark Duffett. (2015) The Effect of Melatonin on Benzodiazepine Discontinuation and Sleep Quality in Adults Attempting to Discontinue Benzodiazepines: A Systematic Review and Meta-Analysis. Drugs & Aging 32:12, pages 1009-1018.
Crossref
Crossref